Zobrazeno 1 - 10
of 40
pro vyhledávání: '"H. El-Bizri"'
Autor:
Mathias Bähr, Thomas Klockgether, Jörg B. Schulz, H. El‐Bizri, Marc Gleichmann, Y. Yokota, G. Buchheim, Sebastian Kügler, Michael Weller
Publikováno v:
Journal of Neurochemistry. 80:755-762
Inhibitor-of-differentiation 2 (Id2) belongs to a family of transcriptional modulators that are characterized by a helix loop helix region but lack the basic amino acid domain. During development, Id2 antagonizes differentiation mediated by the retin
Autor:
Paul B. S. Clarke, H. El-Bizri
Publikováno v:
British Journal of Pharmacology. 113:917-925
1. Chronic administration of nicotinic agonists in vivo increases the density of brain nicotinic binding sites. It has been proposed that this up-regulation results from agonist-induced functional blockade of nicotinic receptors. This hypothesis was
Autor:
Paul B. S. Clarke, H. El-Bizri
Publikováno v:
British Journal of Pharmacology. 111:414-418
1 The chronic nicotinic blockade produced following in vivo administration of chlorisondamine was investigated in vitro. Nicotine-induced [3H]-dopamine release from striatal synaptosomes was used as a measure of central nicotinic receptor function. 2
Publikováno v:
The Journal of comparative neurology. 405(1)
In this report, we have examined the relationship between the onset of neuronal gene transcription and neuronal development by characterizing expression of the early panneuronal Talpha1 alpha-tubulin promoter in developing neurons. In the peripheral
1. Chlorisondamine (CHL), a bisquaternary amine, produces a remarkably long-lasting blockade of central responses to nicotine. The mechanism underlying this blockade is not known. The main aim of this study was to test for possible accumulation of [3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc551f11ad39044feef4d0715a6e7105
https://europepmc.org/articles/PMC1909043/
https://europepmc.org/articles/PMC1909043/
Publikováno v:
British journal of pharmacology. 111(3)
1. The acetylcholinesterase inhibitors physostigmine, neostigmine, tetrahydroaminoacridine (tacrine; THA) and diisopropylfluorophosphate (DFP) were tested for possible direct nicotinic actions in rat striatal synaptosomes preloaded with [3H]-dopamine
Autor:
H. El-Bizri, Paul B. S. Clarke
1. Central nicotinic receptor function examined in vitro, by measuring nicotine-induced [3H]-dopamine release from rat striatal synaptosomes. 2. The agonists (-)-nicotine, acetylcholine, 1,1-dimethyl-4-phenylpiperazinium (DMPP) and cytisine (10(-7)-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c605fe79e30f65285a9774e6dda5a6bf
https://europepmc.org/articles/PMC1909987/
https://europepmc.org/articles/PMC1909987/
Autor:
R. Čapek, Paul B. S. Clarke, B.A. Esplin, Isabelle Chaudieu, H. El-Bizri, Patricia Boksa, M. Quik
Publikováno v:
British journal of pharmacology. 111(2)
1. A single administration of the ganglion blocker, chlorisondamine (10 mg kg-1, s.c.) is known to produce a quasi-irreversible blockade of the central actions of nicotine in the rat. The mechanism of this persistent action is not known. It is also u
Autor:
M. I. Dávila-Garciá, S. S. Oasba, R. A. Houghtling, K. J. Kellar, J. Komourian, M. Ouik, X. Zhang, Z-H. Gong, Agneta Nordberg, Diana L. Donnelly-Roberts, Murali Gopalakrishnan, Stephen P. Arneric, James P. Sullivan, Elzbieta Puchacz, Cynthia Eisenhour, Ronald J. Lucas, Linda Lucero, Peter P. Rowell, Merouane Bencherif, Kathy Fowler, Patrick M. Lippiello, Y. N. Hsu, J. Amin, D. Weiss, L. Wecker, P. B. Sargent, E. N. Garrett, H. L. Wilson, S. D. Matthews, P. B. S. Clarke, H. El-Bizri, J. A. Stitzel, D. A. Farnham, A. C. Collins, S. Leonard, L. E. Adler, P. C. Bickford, M. Hall, Y. Rollins, C. Breese, J. Logel, C. Drebing, W. Byerley, H. Coon, R. Freedman, A. E. Bullock, A. S. Schneider, A. Codilnola, P. Tarroni, M. G. Cattaneo, L. M. Vicentini, F. Clementi, F. Sher
Publikováno v:
Experientia Supplementum ISBN: 9783764350871
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a777a6b53d8e7ae8b73c8481eee7afa0
https://doi.org/10.1007/978-3-0348-7416-8_12
https://doi.org/10.1007/978-3-0348-7416-8_12
Publikováno v:
Molecular pharmacology. 39(3)
Recent work has shown that thymopoietin, a polypeptide with actions in the immune and nervous systems, potently binds to the alpha-bungarotoxin (alpha-BGT) receptor. The present study was done to characterize the interaction of thymopoietin at the ni